Pfizer Inc. (PFE) Guidance & Earnings Results
On 2026-08-04 Pfizer Inc. raised guidance: "Revenue guidance raised by $500M (0.8%) at midpoint; Adj. EPS…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PFEPfizer Inc.Follow PFE — free
—
Price chart with a free account
- Market cap
- 171.2B
- P/E TTM
- 39.5
- Dividend yield
- 5.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 4 Aug 26 | Raised | Revenue guidance raised by $500M (0.8%) at midpoint; Adj. EPS reaffirmed · full year |
| 5 May 26 | Reaffirmed | FY2026: Revenues $59.5B-$62.5B, Adj. EPS $2.80-$3.00, Adj. SI&A $12.5B-$13.5B, Adj. R&D $10.5B-$11.5B · full year |
| 3 Feb 26 | Reaffirmed | Revenue $59.5-62.5B, adjusted EPS $2.80-3.00 · full year |
| 4 Nov 25 | Raised | Adjusted diluted EPS guidance raised to $3.00-$3.15 from $2.90-$3.10; revenue guidance reaffirmed $61-64B · full year |
| 5 Aug 25 | Raised | FY2025 revenue $61.0-64.0B (reaffirmed); FY2025 adjusted diluted EPS $2.90-3.10 (raised from $2.80-3.00); adjusted SI&A expenses $13.1-14.1B (from $13.3-14.3B); adjusted R&D expenses $10.4-11.4B (from $10.7-11.7B); effective tax rate ~13.0% (from ~15.0%) · full year |
Pfizer Inc. — questions
- What guidance did Pfizer Inc. give?
- On 2026-08-04: "Revenue guidance raised by $500M (0.8%) at midpoint; Adj. EPS reaffirmed"
- When does Pfizer Inc. report earnings?
- Pfizer Inc.'s next earnings report is expected on 2026-11-03.
Every figure on this page comes from Pfizer Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.